The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Storz, G., & Imlayt, J. A. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80033-2 · Cited by 1,021
Genetic Control of Isoniazid Metabolism in Man
Evans, D. A. P., Manley, K. A., & McKusick, V. A. (1960) · BMJ · doi:10.1136/bmj.2.5197.485 · Cited by 784
Treatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
N-acetylation pharmacogenetics.
Weber, W. W., & Hein, D. W. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06816-4 · Cited by 648
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Casali, N., Nikolayevskyy, V., Balabanova, Y., Harris, S. R., Ignatyeva, O., Kontsevaya, I., Corander, J., Bryant, J., Parkhill, J., Nejentsev, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2878 · Cited by 473
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Lai, S.-L., Yang, S.-Y., Chang, F.-Y., & Lee, S.-D. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 432
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Nomenclature for N-acetyltransferases
Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J., Evans, D. A. P., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U., Relling, M. V., et al. (1995) · Pharmacogenetics · doi:10.1097/00008571-199502000-00001 · Cited by 412
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D., & McKinney, J. D. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04078.x · Cited by 342
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Seifert, M., Catanzaro, D., Catanzaro, A., & Rodwell, T. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119628 · Cited by 326
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Pym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Pharmacogenetics-based tuberculosis therapy research group, Azuma, J., Ohno, M., Kubota, R., Yokota, S., Nagai, T., Tsuyuguchi, K., Okuda, Y., Takashima, T., Kamimura, S., et al. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1429-9 · Cited by 278
Feldman, W. H. (1964) · Tubercle · doi:10.1016/s0041-3879(64)80058-1 · Cited by 266
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Ohno, M., Yamaguchi, I., Yamamoto, I., Fukuda, T., Yokota, S., Maekura, R., Ito, M., Yamamoto, Y., Ogura, T., Maeda, K., et al. (2000) · PubMed · Cited by 251
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
Machado, D., Couto, I., Perdigão, J., Rodrigues, L., Portugal, I., Baptista, P., Veigas, B., Amaral, L., & Viveiros, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034538 · Cited by 226
Tuberculosis Drug Resistance: A Global Threat
Nachega, J. B., & Chaisson, R. E. (2003) · Clinical Infectious Diseases · doi:10.1086/344657 · Cited by 225
Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase
Bertrand, T., Eady, N. A. J., Jones, J. N., Jesmin, Nagy, J. M., Jamart-Grégoire, B., Raven, E. L., & Brown, K. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402382200 · Cited by 220
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli
Middlebrook, G., & Cohn, M. L. (1953) · Science · doi:10.1126/science.118.3063.297 · Cited by 217
Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
The genetics and biochemistry of isoniazid resistance in
Slayden, R. A., & Barry, C. E. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00359-2 · Cited by 205
Kapur, V., Li, L., Hamrick, M. R., et al. (1995) · PubMed · Cited by 203
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.
Sherman, D. R., Sabo, P. J., Hickey, M. J., Arain, T. M., Mahairas, G. G., Yuan, Y., Barry, C. E., & Stover, C. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6625 · Cited by 202
Li, Z., Kelley, C., Collins, F., Rouse, D., & Morris, S. (1998) · Journal of Infectious Diseases · doi:10.1086/515254 · Cited by 195
Menzies, D., Benedetti, A., Paydar, A., Royce, S., Pai, M., Burman, W., Vernon, A., & Lienhardt, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000150 · Cited by 194
Should We Use N -Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses?
Kinzig-Schippers, M., Tomalik-Scharte, D., Jetter, A., Scheidel, B., Jakob, V., Rodamer, M., Cascorbi, I., Doroshyenko, O., Sörgel, F., & Fuhr, U. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1733-1738.2005 · Cited by 194
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
Parkin, D. P., Vandenplas, S., Botha, F. J., Vandenplas, M. L., Seifart, H. I., van Helden, P. D., van der Walt, B. J., Donald, P. R., & van Jaarsveld, P. P. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154882 · Cited by 190
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Deretic, V., Philipp, W., Dhandayuthapani, S., Mudd, M. H., Curcic, R., Garbe, T., Heym, B., Via, L. E., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17050889.x · Cited by 177
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Johnsson, K., Froland, W. A., & Schultz, P. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2834 · Cited by 160
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Zhang, M., Yue, J., Yang, Y., Zhang, H., Lei, J.-Q., Jin, R., Zhang, X., & Wang, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5477-5482.2005 · Cited by 155
Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex
Rodrigues, L., Machado, D., Couto, I., Amaral, L., & Viveiros, M. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.08.009 · Cited by 153
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex
Wilson, T. M., & Collins, D. M. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.449980.x · Cited by 148
Catalase-peroxidase KatG of Burkholderia pseudomallei at 1.7Å resolution
Carpena, X., Loprasert, S., Mongkolsuk, S., Switala, J., Loewen, P. C., & Fita, I. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00122-0 · Cited by 146
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 139
Pym, A. S., Domenech, P., Honoré, N., Song, J., Deretic, V., & Cole, S. T. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02427.x · Cited by 138
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Heinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Zatman, L. J., Kaplan, N. O., Colowick, S. P., & Ciotti, M. M. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65474-2 · Cited by 128
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 126
Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid
Zhang, Y., Dhandayuthapani, S., & Deretic, V. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13212 · Cited by 120
Dhandayuthapani, S., Zhang, Y., Mudd, M. H., & Deretic, V. P. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.12.3641-3649.1996 · Cited by 119
Guo, H., Seet, Q., Denkin, S. M., Parsons, L. M., & Zhang, Y. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46718-0 · Cited by 115
Cattamanchi, A., Dantes, R., Metcalfe, J. Z., Jarlsberg, L. G., Grinsdale, J. A., Kawamura, L. M., Osmond, D. H., Hopewell, P. C., & Nahid, P. (2008) · Clinical Infectious Diseases · doi:10.1086/595689 · Cited by 114
Lin, T., Melgar, M. M., Kurth, D. G., Swamidass, S. J., Purdon, J., Teresa, T., Gago, G., Baldi, P., Gramajo, H. C., & Tsai, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510580103 · Cited by 113
The Met-Tyr-Trp Cross-link in Mycobacterium tuberculosis Catalase-peroxidase (KatG)
Ghiladi, R. A., Knudsen, G. M., Medzihradszky, K. F., & de Montellano, P. R. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502486200 · Cited by 111
Kelley, C. L., Rouse, D. A., & Morris, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2057 · Cited by 110
Mechanism of isoniazid uptake in Mycobacterium tuberculosis
Bardou, F., Raynaud, C., Ramos, C., et al. (1998) · Microbiology · doi:10.1099/00221287-144-9-2539 · Cited by 109
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
Torres, J., Paul, L. V., Rodwell, T. C., Victor, T. C., Amallraja, A., Elghraoui, A., Goodmanson, A. P., Ramirez-Busby, S. M., Chawla, A., Zadorozhny, V., et al. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.42 · Cited by 107
Sandy, J., Mushtaq, A., Kawamura, A., Sinclair, J., Sim, E., & Noble, M. E. M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00141-9 · Cited by 103
Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
Jenkins, H. E., Zignol, M., & Cohen, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022927 · Cited by 103
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico
Ramaswamy, S. V., Dou, S.-J., Rendón, A., Yang, Z., Cave, M. D., & Graviss, E. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05343-0 · Cited by 103
Ali, A., Hasan, Z., McNerney, R., Mallard, K., Hill-Cawthorne, G. A., Coll, F., Nair, M. B., Pain, A., Clark, T. G., & Hasan, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117771 · Cited by 102
Middlebrook, G. (1952) · PubMed · Cited by 100
Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
Rodrigues, L., Villellas, C., Bailo, R., Viveiros, M., & Aínsa, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01482-12 · Cited by 98
Bhakta, S., Besra, G. S., Upton, A. M., Parish, T., Sholto-Douglas-Vernon, C., Gibson, K. J. C., Knutton, S., Gordon, S., daSilva, R. P., Anderton, M. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031956 · Cited by 98
Robitzek, E. H., & Selikoff, I. J. (1952) · PubMed · doi:10.1164/art.1952.65.4.402 · Cited by 95
Ito, K., Yamamoto, K., & Kawanishi, S. (1992) · Biochemistry · doi:10.1021/bi00161a046 · Cited by 91
Quémard, A., Dessen, A., Sugantino, M., Jacobs, W. R., Sacchettini, J. C., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja950998b · Cited by 90
Timmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3006-3009.2004 · Cited by 90
Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C., & Merola, A. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.404 · Cited by 89
Wei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Mitchison, D. A., Selkon, J. B., & Lloyd, J. (1963) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700860213 · Cited by 88
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 86
Pagán-Ramos, E., Song, J., McFalone, M., Mudd, M. H., & Deretic, V. P. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4856-4864.1998 · Cited by 85
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases
Metcalfe, C. L., Macdonald, I. K., Murphy, E. J., Brown, K. A., Raven, E. L., & Moody, P. C. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707412200 · Cited by 83
Mycobacterium tuberculosisKatG Is a Peroxynitritase
Wengenack, N. L., Jensen, M. P., Rusnak, F. M., & Stern, M. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0358 · Cited by 83
Magliozzo, R. S., & Marcinkeviciene, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8867 · Cited by 82
Treatment Outcomes of Isoniazid-Resistant Tuberculosis Patients, Western Cape Province, South Africa
Jacobson, K. R., Theron, D., Victor, T. C., Streicher, E. M., Warren, R. M., & Murray, M. B. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir406 · Cited by 82
A silent mutation in mabA confers isoniazid resistance on M ycobacterium tuberculosis
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2013) · Molecular Microbiology · doi:10.1111/mmi.12476 · Cited by 80
Jnawali, H. N., Hwang, S. C., Park, Y. K., Kim, H.-J., Lee, Y. S., Chung, G. T., Choe, K. H., & Ryoo, S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.035 · Cited by 79
Baker, L. V., Brown, T., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., & Drobniewski, F. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1455-1464.2005 · Cited by 78
Gupta, A. K., Reddy, V. P., Lavania, M., Chauhan, D. S., Venkatesan, K., Sharma, V. D., Tyagi, A. K., & Katoch, V. M. (2010) · PubMed · Cited by 73
Purohit, R., Rajendran, V., & Sethumadhavan, R. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-010-0785-6 · Cited by 73
Chouchane, S., Girotto, S., Yu, S., & Magliozzo, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207916200 · Cited by 70
Kurth, D. G., Gago, G., de la Iglesia, A., Lyonnet, B. B., Lin, T., Morbidoni, H. R., Tsai, S., & Gramajo, H. C. (2009) · Microbiology · doi:10.1099/mic.0.027714-0 · Cited by 70
Lavender, C. J., Globan, M., Sievers, A. S., Billman‐Jacobe, H., & Fyfe, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4068-4074.2005 · Cited by 70
Lin, S.-Y. G., Probert, W. S., Lo, M. W., & Desmond, E. P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4204-4208.2004 · Cited by 66
Role of Superoxide in Catalase-Peroxidase-Mediated Isoniazid Action against Mycobacteria
Wang, J., Burger, R. M., & Drlica, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.709 · Cited by 60
Davidson, L. A., & Takayama, K. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.1.104 · Cited by 60
Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis
Rouse, D. A., & Morris, S. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1427-1433.1995 · Cited by 59
Hickman, D., Palamanda, J. R., Unadkat, J. D., & Sim, E. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00182-y · Cited by 57
Isoniazid Resistance and the Future of Drug-Resistant Tuberculosis
Cohen, T., Becerra, M. C., & Murray, M. B. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.280 · Cited by 56
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Bulatović, V. M., Wengenack, N. L., Uhl, J. R., Hall, L., Roberts, G. D., Cockerill, F. R., & Rusnak, F. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2765-2771.2002 · Cited by 56
Deretic, V. P., Pagán-Ramos, E., Zhang, Y., Dhandayuthapani, S., & Via, L. E. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1557 · Cited by 54
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis
Heym, B., Saint‐Joanis, B., & Cole, S. T. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0208 · Cited by 54
Isolation and Characterization of Catalase Produced by Mycobacterium tuberculosis
Diaz, G. A., & Wayne, L. G. (1974) · American Review of Respiratory Disease · doi:10.1164/arrd.1974.110.3.312 · Cited by 53
Hu, Y., Hoffner, S. E., Jiang, W., Wang, W., & Xu, B. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-43 · Cited by 50
Nagy, J. M., Cass, A. E. G., & Brown, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31265 · Cited by 49
Devi, B. G., Shaila, M. S., Ramakrishnan, T. V., & Gopinathan, K. P. (1975) · Biochemical Journal · doi:10.1042/bj1490187 · Cited by 45
Bardou, F., Quémard, A., Dupont, M.-A., Horn, C., Marchal, G., & Daffé, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2459 · Cited by 44
Leung, E. T. Y., Ho, P., Yuen, K., Woo, W. L., Lam, T., Kao, R. Y. T., Seto, W., & Yam, W. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1075-1078.2006 · Cited by 44
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India
Unissa, A. N., Selvakumar, N., Narayanan, S., & Narayanan, P. R. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.013 · Cited by 39
Self-citationWinder, F. G., Collins, P., & Rooney, S. A. (1970) · Biochemical Journal · doi:10.1042/bj1170027pa · Cited by 36
Wengenack, N. L., Lopes, H., Kennedy, M. J., Tavares, P., Pereira, A. S., Moura, I., Moura, J. J. G., & Rusnak, F. M. (2000) · Biochemistry · doi:10.1021/bi001239v · Cited by 36
Catalase and Peroxidase in Mycobacteria
WINDER, F. G. (1960) · American Review of Respiratory Disease · doi:10.1164/arrd.1960.81.1p1.68 · Cited by 35
Characterization of the W321F mutant of Mycobacterium tuberculosis catalase-peroxidase KatG
Yu, S., Chouchane, S., & Magliozzo, R. S. (2002) · Protein Science · doi:10.1110/ps.09902 · Cited by 34
Mycobacterium tuberculosis: a model system for structural genomics
Smith, C. V., & Sacchettini, J. C. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.004 · Cited by 27
Exploring the Structure and Function of the Mycobacterial KatG Protein Using trans -Dominant Mutants
DeVito, J. A., & Morris, S. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.188-195.2003 · Cited by 27
Unissa, A. N., Selvakumar, N., Narayanan, S., Suganthi, C., & Hanna, L. E. (2015) · BioMed Research International · doi:10.1155/2015/257983 · Cited by 26
Self-citationOxidation of isonicotinic acid hydrazide by the peroxidase system
Zinner, K., Vidigal, C. C. C., Durán, N., & Cilento, G. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90059-5 · Cited by 25
Herrera, L., Valverde, A., Sáiz, P. A., Sáez-Nieto, J. A., Portero, J. L., & Jiménez, M. S. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.032 · Cited by 23
Catalase–peroxidase activity has no influence on virulence in a murine model of tuberculosis
Cardona, P.-J., Gordillo, S., Amat, I., Díaz, J., Lonca, J., Vilaplana, C., Pallarés, Á., Llatjós, R., Ariza, A., & Ausina, V. (2003) · Tuberculosis · doi:10.1016/s1472-9792(03)00056-8 · Cited by 22
Hearn, M. J., & Cynamon, M. H. (2003) · Drug design and discovery · doi:10.1080/10559610390450705 · Cited by 22
Morse, W. C., Weiser, O. L., Kuhns, D. M., Fusillo, M. H., Dail, M. C., & Evans, J. R. (1954) · PubMed · doi:10.1164/art.1954.69.3.464 · Cited by 19
Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
Whitney, J. B., & Wainberg, M. A. (2002) · McGill Journal of Medicine · doi:10.26443/mjm.v6i2.686 · Cited by 19
THE METABOLISM OF ISONIAZID AND OTHER HYDRAZIDES BY MYCOBACTRIA
Youatt, J. (1960) · Immunology and Cell Biology · doi:10.1038/icb.1960.25 · Cited by 18
Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
Takayama, K., Armstrong, E. L., & David, H. L. (1974) · PubMed · doi:10.1164/arrd.1974.110.1.43 · Cited by 13
Unissa, A. N., & Elizabeth, H. L. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.08.011 · Cited by 10
Self-citationUnissa, A. N., Narayanan, S., Suganthi, C., & Selvakumar, N. (2011) · International journal of molecular and clinical microbiology · Cited by 5
Self-citation
Cited by
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
(2023) · doi:10.1002/prot.26504 · Cited by 2
Metadata
- Authors
- Unissa, A. N., Subbian, S., Hanna, L. E., & Selvakumar, N.
- Venue
- Infection, Genetics and Evolution
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 45
- Pages
- 474-492
- ISSN
- 1567-1348 (ISSN-L)
- OpenAlex
- W2516060412
- Cited by
- 300
- References
- 144
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.